Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial

NCT02785458 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02785458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02785458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Completed
Start date
June 8, 2017
Completion date
September 20, 2019
Enrollment
1,005 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk medications